The Company expects the additional product characterisation and specification testing will be completed by Q2 CY2024.(that's THIS Q!!) Then onwards and upwards to clinical trials!!!
Ann: Appendix 4C - Quarterly - 31 March 2024, page-3
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $7.52K | 1.211M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 2837125 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2301812 | 3 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |